Serum Free Immunoglobulin Light Chain Evaluation as a Marker of Impact From Intraclonal Heterogeneity on Myeloma Outcome
Blood - United States
doi 10.1182/blood-2013-12-542662
Full Text
Open PDFAbstract
Available in full text
Date
May 29, 2014
Authors
Publisher
American Society of Hematology